Abstract
Background
Among travelers returning from the tropics, Entamoeba spp. are among the most frequently detected intestinal parasites, mainly the presumable apathogenic E. dispar and the pathogenic E. histolytica.
Methods
Among 5,378 travelers seeking diagnosis and treatment for intestinal infections at the travel clinic of the University of Munich between 2005 and 2009, 103 laboratory-confirmed amebiasis cases were detected. The study compares the results of various diagnostic tests among these patients, analyzes data on co-infections and clinical symptoms, and determines the risk for acquiring amebiasis.
Results
Initial screening tests (stool microscopy, coproantigen enzyme-linked immunosorbent assay [ELISA]) were positive in 82.5 and 93.9%, respectively. Fecal samples from patients with positive screening test results were subjected to polymerase chain reaction (PCR), which detected E. histolytica in 9.7% and E. dispar in 88.3% of the cases. The majority of E. histolytica cases and more than half of the E. dispar cases had intestinal symptoms typical for amebiasis. In 53.4% of the cases, intestinal co-infections were found, mostly Blastocystis hominis (39.8%), Giardia lamblia (10.7%), Campylobacter spp. (4.9%), and Salmonella typhi (2.9%). The risk for travelers to be infected with E. histolytica or E. dispar was highest for destinations in West Africa, East Africa, and South and South-East Asia.
Conclusion
Stool microscopy and coproantigen ELISA are appropriate screening tests for intestinal Entamoeba infections among travelers, but intestinal co-infections are common. PCR is highly recommended as the diagnostic method of choice for the differentiation of Entamoeba spp. The presumable apathogenic E. dispar seems to provoke intestinal symptoms.
Similar content being viewed by others
References
Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986;8:228–38. Review.
WHO/PAHO/UNESCO. A consultation with experts on amoebiasis. Mexico City, Mexico 28–29 January, 1997. Epidemiol Bull. 1997;18:13–4.
Tannich E, Burchard GD. Amöbiasis und andere Amöbeninfektionen. In: Löscher T, Burchard GD, editors. Tropenmedizin in Klinik und Praxi. Stuttgart: Thieme Verlag; 2010. p. 645.
Ali IK, Hossain MB, Roy S, Ayeh-Kumi PF, Petri WA Jr, Haque R, Clark CG. Entamoeba moshkovskii infections in children, Bangladesh. Emerg Infect Dis. 2003;9:580–4.
Gutiérrez-Cisneros MJ, Cogollos R, López-Vélez R, Martín-Rabadán P, Martínez-Ruiz R, Subirats M, Merino FJ, Fuentes I. Application of real-time PCR for the differentiation of Entamoeba histolytica and E. dispar in cyst-positive faecal samples from 130 immigrants living in Spain. Ann Trop Med Parasitol. 2010;104:145–9.
Cavallo JD, Garrabé E. Infectious aetiologies of travelers’ diarrhoea. Med Mal Infect. 2007;37:722–7.
Chapman PA. Cryptosporidiosis: recent trends in epidemiology, diagnosis, and treatment. Serodiagn Immunother Infect Dis. 1988;2:311–7.
Garcia LS, Shimizu RY, Bernard CN. Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay. J Clin Microbiol. 2000;38:3337–40.
Paschke C, Apelt N, Fleischmann E, Perona P, Walentiny C, Löscher T, Herbinger KH. Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea. Clin Microbiol Infect 2010; [Epub ahead of print].
Clark CG. The evolution of Entamoeba, a cautionary tale. Res Microbiol. 2000;151:599–603.
Farthing MJG, Cevallos AM, Kelly P. Intestinal protozoa. In: Cook GC, editor. Manson’s tropical diseases. Amsterdam: Elsevier and WB Saunders; 2003. p. 1373–410
Haque R, Neville LM, Hahn P, Petri WA Jr. Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol. 1995;33:2558–61.
Tannich E. The laboratory diagnosis of Entamoeba histolytica infections. J Lab Med. 2004;28:491–7.
Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa? Am J Trop Med Hyg. 1995;53:36–9.
Khairnar K, Parija SC. A novel nested multiplex polymerase chain reaction (PCR) assay for differential detection of Entamoeba histolytica, E. moshkovskii and E. dispar DNA in stool samples. BMC Microbiol. 2007;7:47.
Huston CD, Haque R, Petri WA Jr. Molecular-based diagnosis of Entamoeba histolytica infection. Expert Rev Mol Med. 1999;22:1–11.
Haque R, Ali IKM, Akther S, Petri WA Jr. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol. 1998;36:449–52.
Zeehaida M, Wan Nor Amilah WA, Amry AR, Hassan S, Sarimah A, Rahmah N. A study on the usefulness of Techlab Entamoeba histolytica II antigen detection ELISA in the diagnosis of amoebic liver abscess (ALA) at Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia. Trop Biomed. 2008;25:209–16.
Jelinek T, Peyerl G, Löscher T, Nothdurft HD. Evaluation of an antigen-capture enzyme immunoassay for detection of Entamoeba histolytica in stool samples. Eur J Clin Microbiol Infect Dis. 1996;15:752–5.
Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain KC. Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in a setting of nonendemicity. Clin Infect Dis. 1999;29:1315–8.
el-Hamshary EM, el-Shewy KA, Hegazy MM, Zakaria H. Diagnostic potentials of copro-antigen detection based ELISA, compared to microscopy in intestinal amoebiasis. J Egypt Soc Parasitol. 2004;34:601–10.
Gonzalez-Ruiz A, Haque R, Rehman T, Aguirre A, Hall A, Guhl F, Warhurst DC, Miles MA. Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assay. J Clin Microbiol. 1994;32:964–70.
Aguirre A, Warhurst DC, Guhl F, Frame IA. Polymerase chain reaction-solution hybridization enzyme-linked immunoassay (PCR-SHELA) for the differential diagnosis of pathogenic and non-pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1995;89:187–8.
Blessmann J, Buss H, Nu PA, Dinh BT, Ngo QT, Van AL, Alla MD, Jackson TF, Ravdin JI, Tannich E. Real-time PCR for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in fecal samples. J Clin Microbiol. 2002;40:4413–7.
Hamzah Z, Petmitr S, Mungthin M, Leelayoova S, Chavalitshewinkoon-Petmitr P. Differential detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii by a single-round PCR assay. J Clin Microbiol. 2006;44:3196–200.
Parija SC, Khairnar K. Entamoeba moshkovskii and Entamoeba dispar-associated Infections in Pondicherry, India. J Health Popul Nutr. 2005;23:292–5.
Roy S, Kabir M, Mondal D, Ali IK, Petri WA Jr, Haque R. Real-time-PCR assay for diagnosis of Entamoeba histolytica infection. J Clin Microbiol. 2005;43:2168–72.
Haque R, Roy S, Siddique A, Mondal U, Rahman SM, Mondal D, Houpt E, Petri WA Jr. Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg. 2007;76:713–7.
Leippe M, Ebel S, Schoenberger OL, Horstmann RD, Müller-Eberhard HJ. Pore-forming peptide of pathogenic Entamoeba histolytica. Proc Natl Acad Sci USA. 1991;88:7659–63.
Munford RS, Sheppard PO, O’Hara PJ. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J Lipid Res. 1995;36:1653–63.
Leippe M. Amoebapores. Parasitol Today. 1997;13:178–83.
Nickel R, Ott C, Dandekar T, Leippe M. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity. Eur J Biochem. 1999;265:1002–7.
Ximénez C, Cerritos R, Rojas L, Dolabella S, Morán P, Shibayama M, González E, Valadez A, Hernández E, Valenzuela O, Limón A, Partida O, Silva EF. Human amebiasis: breaking the paradigm? Int J Environ Res Public Health. 2010;7:1105–20.
Vohra H, Bhatti HS, Ganguly NK, Mahajan RC. Virulence of pathogenic and non-pathogenic zymodemes of Entamoeba histolytica (Indian strains) in guinea-pigs. Trans R Soc Trop Med Hyg. 1989;83:648–50.
Garcia LS. Diagnostic medical parasitology. 4th edn. Washington, DC: ASM Press; 2001.
Hossain A, Bolbol AS, Chowdhury MN, Bakir TM. Indirect haemagglutination (IHA) test in the serodiagnosis of amoebiasis. J Hyg Epidemiol Microbiol Immunol. 1989;33:91–7.
Funke M, Felgner P, Geister R. Quantification of amebae specific antibodies as “Multiple of normal activity (MONA)” with a standardized enzyme immunoassay (EIA). Zentralbl Bakteriol Mikrobiol Hyg A. 1981;251:126–33.
Acknowledgments
The authors thank all of the patients in this study for their cooperation.
Conflict of interest
None of the authors had any conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herbinger, KH., Fleischmann, E., Weber, C. et al. Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers. Infection 39, 527–535 (2011). https://doi.org/10.1007/s15010-011-0155-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-011-0155-z